STUDY THE NEPHRO-PROTECTIVE EFFECTS OF LOSARTAN ON RATS
In the Reduction of Endpoints in NIDDM (noninsulin–dependent diabetes mellitus) with the Angiotensin II Antagonist Losartan study (RENAAL study), Losartan reduced the risk of the doubling of serum creatinine concentration by 25% and of end stage renal disease (ESRD) by 28%. Methods: 40 albino rats...
Zapisane w:
| 1. autor: | |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Al-Azhar University, Faculty of Pharmacy
2014-03-01
|
| Seria: | Al-Azhar Journal of Pharmaceutical Sciences |
| Hasła przedmiotowe: | |
| Dostęp online: | https://ajps.journals.ekb.eg/article_6967_e6ca9db5c9ac52eb0ee2f696b04017ce.pdf |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|